Adenoid hypertrophy in children with allergic disease and influential factors

Muhammed Fatih Evcimik1, Mahmut Dogru2, Ahmet Adnan Cirik3

  • 1Istanbul Medipol University, Faculty of Medicine, Department of Otorhinolaryngology - Head & Neck Surgery, Istanbul, Turkey.

Insights

Adenoid hypertrophy (AH) is more common in children with allergies. Allergic rhinitis and cigarette smoke exposure are key risk factors for developing AH in children.

Area of Science:

  • Pediatrics
  • Allergology
  • Otolaryngology

Background:

  • Adenoid hypertrophy (AH) is linked to comorbidities like sleep apnea, otitis, and sinusitis, particularly in children with allergic diseases.
  • Understanding the patient profile and risk factors for AH is crucial for early diagnosis and management in allergic children.

Purpose of the Study:

  • To identify the patient characteristics associated with a higher incidence of adenoid hypertrophy (AH).
  • To determine the influential factors contributing to the development of AH in children with allergic conditions.

Main Methods:

  • A study involving 1322 children with allergic conditions and 100 controls without allergies.
  • Diagnosis of AH confirmed via patient history, endoscopic examination, radiology, and skin prick testing for allergens.

Main Results:

  • Adenoid hypertrophy (AH) was diagnosed in 12.4% of children with allergic disease versus 3% in controls.
  • Allergic rhinitis and exposure to cigarette smoke at home were significantly more frequent in children with AH.
  • Logistic regression confirmed allergic rhinitis and cigarette smoke exposure as significant risk factors for AH.

Conclusions:

  • The incidence of AH is significantly higher in children with allergic diseases compared to non-allergic children.
  • Allergic rhinitis and environmental exposure to cigarette smoke are identified as primary risk factors for AH development.
  • Routine screening for AH is recommended in children presenting with allergic rhinitis or significant smoke exposure.
Abstract

Related Concept Videos

Chronic Pharyngitis01:23

Chronic Pharyngitis

Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
15.8K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
5.0K
Tonsillitis I: Introduction01:30

Tonsillitis I: Introduction

Tonsillitis is inflammation of the tonsils, which are two lymphoid tissue masses at the back of the throat. This condition can cause discomfort and irritation in the throat.
Etiology
Three primary contributing factors have been identified.
3.6K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.7K
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
2.3K
Drugs Used in Upper Respiratory Disorders: Overview01:16

Drugs Used in Upper Respiratory Disorders: Overview

Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
1.0K